TMEM176A
Transmembrane protein 176A
Also known as: HCA112, MS4B1, T176A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96HP8
- Gene
- TMEM176A
- Ensembl
- ENSG00000002933
- Chromosome
- 7
- Canonical length
- 235 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Predicted to act upstream of or within negative regulation of dendritic cell differentiation. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q96HP8|TMEM176A
1 MGTADSDEMA PEAPQHTHID VHIHQESALA KLLLTCCSAL RPRATQARGS SRLLVASWVM
61 QIVLGILSAV LGGFFYIRDY TLLVTSGAAI WTGAVAVLAG AAAFIYEKRG GTYWALLRTL
121 LTLAAFSTAI AALKLWNEDF RYGYSYYNSA CRISSSSDWN TPAPTQSPEE VRRLHLCTSF
181 MDMLKALFRT LQAMLLGVWI LLLLASLTPL WLYCWRMFPT KGKRDQKEML EVSGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM176A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 1,278 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,278 nTPM
- kidney: 352 nTPM
- small intestine: 191 nTPM
- rectum: 142 nTPM
- colon: 135 nTPM
- gallbladder: 122 nTPM
Single-cell type
- enterocytes: 1,156 nCPM
- hepatocytes: 1,030 nCPM
- epididymal efferent duct absorptive cells: 462 nCPM
- colonocytes: 344 nCPM
- tuft cells: 311 nCPM
- enteric transient amplifying cells: 228 nCPM
Immune cell
- classical monocyte: 147 nTPM
- intermediate monocyte: 99 nTPM
- total PBMC: 53 nTPM
- non-classical monocyte: 46 nTPM
- myeloid DC: 31 nTPM
- eosinophil: 13 nTPM
Brain region
- medulla oblongata: 65 nTPM
- white matter: 63 nTPM
- spinal cord: 61 nTPM
- midbrain: 50 nTPM
- hypothalamus: 49 nTPM
- pons: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.77
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM176A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM176A as an antibody target. Whether an autoantibody or antibody against TMEM176A could matter depends on whether native TMEM176A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM176A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM176A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...